Loading...
•
Dec 31, 2024
American Well Q4 2024 Earnings Report
Amwell announced its financial results for the fourth quarter and full year ended December 31, 2024.
Key Takeaways
Amwell reported a total revenue of $71.0 million for Q4 2024, with a net loss of ($44.6) million. The company achieved a gross margin of 48% and an adjusted EBITDA of ($22.8) million, showing an improvement compared to the previous quarter.
Total revenue for Q4 2024 was $71.0 million.
Net loss for Q4 2024 was ($44.6) million, a slight increase from ($44.0) million in Q3 2024.
Adjusted EBITDA for Q4 2024 was ($22.8) million, an improvement from ($31.0) million in Q3 2024.
Gross margin for Q4 2024 was 48%.
Revenue by Segment
Forward Guidance
Amwell provided financial guidance for 2025, expecting revenue between $250 million and $260 million, AMG visits between 1.3 million and 1.35 million, and adjusted EBITDA between ($55) million and ($45) million. The company also aims to achieve positive cash flow in 2026.
Positive Outlook
- Projected revenue for 2025 is between $250 million and $260 million.
- Anticipated AMG visits for 2025 are between 1.3 million and 1.35 million.
- Adjusted EBITDA for 2025 is expected to be between ($55) million and ($45) million, indicating an improvement from 2024.
- Q1 2025 revenue is projected to be between $59 million and $61 million.
- The company's objective is to achieve positive cash flow in 2026.
Challenges Ahead
- The 2025 revenue guidance reflects the divestiture of Amwell Psychiatric Care.
- Adjusted EBITDA for 2025 is still projected to be negative.
- Q1 2025 adjusted EBITDA is expected to be negative, between ($18) million and ($20) million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...